Geneyx Genomex Ltd.

Heading to ASHG 2026 in Montréal (October 20–24)? Come explore GAIA with us at Booth 311. Geneyx is a multi-agentic platform for analysis and interpretation of multiomics data, helping clinical and research organizations turn complex sequencing data into actionable insights. At the booth, you'll see: • GAIA, the Geneyx AI suite for genetic analysis A live demo of how GAIA harnesses AI across the workflow, from variant prioritization to reporting. • PacBio integration Our integration with PacBio's secondary analysis pipeline, for an end-to-end long-read genomics workflow, from raw data to interpretation. • MultiOmics expansion How Geneyx takes you from short- and long-read data to multiomics analysis, with DNA, RNA and methylation evidence in a single interpretation workflow. Meet our team at the booth: Willem Haagmans, VP Global Sales Eli Sward, PhD, Associate Director, Field Application Specialist Dana Odenbeck, Commercial Director Want to make sure we have time for you? Reply to this email to book a meeting or bring your toughest case and stop by. 📍 Booth 311 | ASHG Annual Meeting, Montréal | October 20–24, 2026 See you in Montréal!

One case. Multiple layers of evidence. One unified interpretation platform. Geneyx is expanding its multiomics capabilities by integrating EpiSign Inc. METRIC into Geneyx Analysis, enabling DNA methylation episignatures to be analyzed alongside genomic, phenotypic, and clinical evidence in a single platform. For laboratories and geneticists, this means: A more complete view of complex rare disease cases Integrated genomic and epigenomic interpretation Support for microarray, short-read, and long-read technologies Greater insight from 5-base sequencing workflows Faster, more confident clinical decision-making With access to more than 300 disease-associated episignatures, EpiSign METRIC brings over ten years of curated episignature expertise and reference data directly into Illumina 5-base, PacBio HiFi, and Oxford Nanopore Technologies for sequencing workflows. As rare disease diagnostics evolve beyond single-modality analysis, Geneyx continues to advance its vision of a unified multiomics interpretation platform where every relevant layer of evidence contributes to better answers for every case. #Geneyx #EpiSign #RareDisease #Genomics #Epigenomics #MultiOmics #ClinicalGenomics #LongReadSequencing #PrecisionMedicine

We’re excited to sponsor PacBio PRISM 2026 in Barcelona, San Diego, and Fukuoka. Join us and a global community advancing genomics through long-read data analysis with Geneyx Analysis. We look forward to connecting, sharing insights, and collaborating throughout the event. See you there? Learn more and register: https://bit.ly/4lLBd10 #PacBioPRISM

From data to decisions: Geneyx offers Clinical Interpretation Services that are fast, accurate, compliant, and signed. Our system streamlines the journey from FASTQ/VCF to a fully annotated, signed clinical report, ensuring laboratories and hospitals can deliver results with confidence. ACMG guidelines, HIPAA/GDPR compliance, and full transparency are built into every interpretation. #ClinicalGenomics #GeneticTesting #NGS #PrecisionMedicine #ASHG2025 ➡️ Connect with us at ASHG 2025, Booth #1225.

The Hereditary Cancer Panel powered by Oxford Nanopore Technologies brings targeted sequencing to the next level with adaptive sampling. Together with Geneyx’s analysis and interpretation platform, we enable faster, more accurate insights for oncology research and patient care. Meet us at ASHG 2025 – Booth #1225 and see how we are solving the unsolved in genomics. #CancerGenomics #Oncology #LongRead #AdaptiveSampling #ASHG2025 #Geneyx

Unlock deeper insights with Geneyx DNA–RNA Analysis. By integrating RNA-seq with DNA-seq, our system enables side-by-side analysis and the detection of gene fusions and complex genomic rearrangements. This combined view empowers clinicians and researchers to uncover mechanisms that single-layer analysis might miss. #MultiOmics #RNAseq #DNAseq #GeneFusions #Genomics #ASHG2025 ➡️ Swipe to explore how AI and automation turn complexity into clarity.